Ixekizumab Gets FDA Nod for Active Psoriatic Arthritis

Psoriatic arthritis is the second approved indication for Taltz in the United States.

Source: ConsultantLive - December 12, 2017 Category: Internal Medicine Authors: Rheumatology Network Staff Tags: Psoriatic Arthritis Source Type: news